Galapagos NV
GLPG
#4563
Rank
A$3.17 B
Marketcap
A$47.56
Share price
-0.57%
Change (1 day)
13.82%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): A-$0.71

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is A-$0.51. In 2024 the company made an earnings per share (EPS) of A$1.75 a decrease over its 2023 EPS that were of A$5.34.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.71-140.21%
2024A$1.75-67.16%
2023A$5.34-199.64%
2022A-$5.3699.03%
2021A-$2.69-68.98%
2020A-$8.68-298.06%
2019A$4.38-554.64%
2018A-$0.96-77.18%
2017A-$4.23-326.21%
2016A$1.87-134.19%
2015A-$5.47-371.34%
2014A$2.01-445.98%
2013A-$0.5832.88%
2012A-$0.44-82.07%
2011A-$2.44-817.9%
2010A$0.3412.73%
2009A$0.30-120.79%
2008A-$1.45-37.67%
2007A-$2.3339.64%
2006A-$1.6728.17%
2005A-$1.306.25%
2004A-$1.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
A$4.57-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$15.72-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$5.58-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
A$2.04-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
A-$2.21 333.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.13-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$0.95-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$5.41-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$11.43-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA